IL1B and cryopyrin-associated periodic syndrome: The availability of anti-IL-1 treatment has dramatically changed the long-term prognosis and the quality of life of CAPS patients with a mild and intermediate phenotypes that are usually transmitted with the typical autosomal pattern.